BLFS BioLife Solutions, Inc.

NASDAQ
$35.07

BioLife Solutions, Inc. (BLFS) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is $0.01 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.3% since its last earnings release on August 6, 2026.

BioLife Solutions Beat Consensus Estimates
Thursday, August 6, 2026 · 4:03 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 4:05 PM ET
Earnings Whisper
-
vs $0.01
Rev est $29.03M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $34.90

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BioLife Solutions, Inc.

BioLife Solutions Inc offers patented biopreservation media products, generic formulations of blood stem cell freezing media products, custom product formulation packaging services, and contract aseptic manufacturing formulation.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 1 ETFs, by dollar flow